Membrane homeostasis in adipose physiology and obesity
脂肪生理学和肥胖中的膜稳态
基本信息
- 批准号:10276825
- 负责人:
- 金额:$ 48.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-22 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdipocytesAdipose tissueAffectAnimalsArachidonic AcidsAutomobile DrivingBioenergeticsBrown FatCatabolismCell NucleusCellsCellular MorphologyCollaborationsDataDefectDiabetes MellitusDietDietary FatsDietary Fatty AcidEnergy MetabolismEnvironmentEnzymesEquilibriumExposure toFGF21 geneGene ExpressionGoalsHepaticHigh Fat DietHomeostasisIntakeKnockout MiceLaboratoriesLinkLinoleic AcidsLipidsMediator of activation proteinMembraneMembrane LipidsMetabolicMetabolic DiseasesMitochondriaModelingMorphologyMusNutrientObesityOrganellesPathologicPathway AnalysisPathway interactionsPhenotypePhospholipidsPhysiologicalPhysiologyPolyunsaturated Fatty AcidsPopulationPredispositionProcessProductionPublishingRegulationRegulatory PathwayResistanceRespirationRoleSignal TransductionStressTestingTimeTissue ExpansionTissue membraneTissuesUp-Regulationadipocyte differentiationbiological adaptation to stressdetection of nutrientdiet-induced obesitydietarydietary excessendoplasmic reticulum stressenergy balancefatty acid oxidationgenetic manipulationinterestloss of functionmitochondrial membranemouse modelnovelobesity developmentobesogenicoxidationpatch clampresponsethermal stress
项目摘要
ABSTRACT
A major long-term goal of our laboratory is to delineate regulatory mechanisms that control adipocyte
development and systemic physiology. This proposal will address a new regulatory pathway involved in
adipocyte nutrient sensing, adipose tissue physiology, and adipose depot-specific energy expenditure. The
proposed studies are focused on understanding how dynamic regulation adipocyte membrane composition
contributes to the control of whole-body metabolic homeostasis in living animals. Preliminary data implicates
the phospholipid remodeling enzyme Lpcat3 as novel mechanistic link between dietary fatty acid intake,
adipose tissue homeostasis, and susceptibility to obesity. This proposal builds upon our preliminary
discoveries to address important questions regarding the relationship of membrane lipid composition to
adipose tissue function and systemic physiology and energy balance. We have previously shown that the
enzyme Lpcat3 is uniquely required for the incorporation of the 6 polyunsaturated fatty acids into
phospholipids. Our preliminary data reveal that adipose Lpcat3 expression is induced in the setting of cold
exposure or diet-induced obesity. Moreover, initial characterization of mice lacking Lpcat3 selectively in
adipose tissues has revealed two distinct phenotypes: one traced to white adipose tissue (WAT) and one
traced to brown adipose tissue (BAT). Adipose Lpcat3 KO mice fed a high-fat diet develop a lipodystrophic
phenotype are unable to appropriately expand their WAT, leading to ectopic hepatic lipid accumulation and the
compensatory upregulation of fatty acid oxidation in WAT. At the same time, BAT Lpcat3 KO mice show an
abnormal response to cold challenge, characterized by marked ER stress. A striking commonality between
these WAT and BAT KO models is the compensatory production of FGF21 in an apparent effort to maintain
energy homeostasis. We hypothesize that the fine tuning of adipose tissue membrane composition by Lpcat3
is a critical adaptive response to cold and dietary challenge that permits optimal lipid storage and catabolic
function in a range of environments. We will address these hypotheses with the following specific aims.
Specific Aim 1 is to elucidate the role of membrane phospholipid remodeling in nutrient sensing and healthy
adipose tissue expansion. Specific Aim 2 is to determine the role of phospholipid remodeling in BAT function
and response to thermal stress.
抽象的
我们实验室的一个主要长期目标是描绘控制脂肪细胞的调节机制
该提案将解决涉及的新调控途径。
脂肪细胞营养感应、脂肪组织生理学和脂肪库特定的能量消耗。
拟议的研究重点是了解如何动态调节脂肪细胞膜组成
初步数据表明,有助于控制活体动物的全身代谢稳态。
磷脂重塑酶 Lpcat3 作为膳食脂肪酸摄入之间的新机制联系,
脂肪组织稳态和肥胖易感性该提议建立在我们的初步研究基础上。
解决有关膜脂成分与膜脂成分之间关系的重要问题的发现
脂肪组织功能与全身生理学和能量平衡我们之前已经表明。
Lpcat3 酶是将 6 多不饱和脂肪酸掺入
我们的初步数据表明,脂肪 Lpcat3 表达在寒冷环境下被诱导。
此外,选择性缺乏 Lpcat3 的小鼠的初步特征。
脂肪组织揭示了两种不同的表型:一种可追溯到白色脂肪组织(WAT),另一种可追溯到白色脂肪组织(WAT)
追踪到棕色脂肪组织(BAT),喂养高脂肪饮食的脂肪 Lpcat3 KO 小鼠出现脂肪营养不良。
表型无法适当扩大其 WAT,导致异位肝脂质积累和
WAT 中脂肪酸氧化的代偿性上调同时,BAT Lpcat3 KO 小鼠表现出
对寒冷挑战的异常反应,其特征是明显的内质网应激。
这些 WAT 和 BAT KO 模型是 FGF21 的补偿生产,显然是为了维持
我们发现 Lpcat3 对脂肪组织膜组成的微调。
是对寒冷和饮食挑战的关键适应性反应,可实现最佳的脂质储存和分解代谢
我们将通过以下具体目标来解决这些假设。
具体目标 1 是阐明膜磷脂重塑在营养传感和健康中的作用
具体目标 2 是确定磷脂重塑在 BAT 功能中的作用。
和对热应力的响应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER J TONTONOZ其他文献
PETER J TONTONOZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER J TONTONOZ', 18)}}的其他基金
Lipid storage and utilization in physiology and obesity
生理学和肥胖中的脂质储存和利用
- 批准号:
10663760 - 财政年份:2023
- 资助金额:
$ 48.46万 - 项目类别:
Lipid storage and utilization in physiology and obesity
生理学和肥胖中的脂质储存和利用
- 批准号:
10663760 - 财政年份:2023
- 资助金额:
$ 48.46万 - 项目类别:
Membrane homeostasis in adipose physiology and obesity
脂肪生理学和肥胖中的膜稳态
- 批准号:
10611472 - 财政年份:2021
- 资助金额:
$ 48.46万 - 项目类别:
Membrane homeostasis in adipose physiology and obesity
脂肪生理学和肥胖中的膜稳态
- 批准号:
10455597 - 财政年份:2021
- 资助金额:
$ 48.46万 - 项目类别:
The Nuclear Receptor-Aster Pathway in Enterohepatic Metabolism
肠肝代谢中的核受体-Aster途径
- 批准号:
10094838 - 财政年份:2020
- 资助金额:
$ 48.46万 - 项目类别:
The Nuclear Receptor-Aster Pathway in Enterohepatic Metabolism
肠肝代谢中的核受体-Aster途径
- 批准号:
10654700 - 财政年份:2020
- 资助金额:
$ 48.46万 - 项目类别:
The Nuclear Receptor-Aster Pathway in Enterohepatic Metabolism
肠肝代谢中的核受体-Aster途径
- 批准号:
10263359 - 财政年份:2020
- 资助金额:
$ 48.46万 - 项目类别:
The Nuclear Receptor-Aster Pathway in Enterohepatic Metabolism
肠肝代谢中的核受体-Aster途径
- 批准号:
10437873 - 财政年份:2020
- 资助金额:
$ 48.46万 - 项目类别:
相似国自然基金
巨噬细胞GP73-CXCL5调节脂肪组织适应性产热的机制研究
- 批准号:32300573
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
不同脂肪组织及其驻留巨噬细胞调控小鼠禁食稳态的系统研究
- 批准号:32301235
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MYO9B缺失调控脂肪组织巨噬细胞代谢重编程促进肥胖相关胰岛素抵抗的机制研究
- 批准号:82300948
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Arid5b调控Treg细胞脂肪组织适应性发育和代谢调控功能及机制探究
- 批准号:82371752
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Them1 Inhibitors for the Management of Non-Alcoholic Fatty Liver Disease
Them1 治疗非酒精性脂肪肝的抑制剂
- 批准号:
10666090 - 财政年份:2023
- 资助金额:
$ 48.46万 - 项目类别:
PDGFRB Signaling in Progressive Skin Disease
进行性皮肤病中的 PDGFRB 信号传导
- 批准号:
10583948 - 财政年份:2023
- 资助金额:
$ 48.46万 - 项目类别:
Mechanical properties of adipose tissue and its effect on breast cancer
脂肪组织的力学特性及其对乳腺癌的影响
- 批准号:
10737165 - 财政年份:2023
- 资助金额:
$ 48.46万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10703523 - 财政年份:2023
- 资助金额:
$ 48.46万 - 项目类别:
Hypertrophic adipocytes as biophysical mediators of breast cancer progression
肥大脂肪细胞作为乳腺癌进展的生物物理介质
- 批准号:
10751284 - 财政年份:2023
- 资助金额:
$ 48.46万 - 项目类别: